News
US pharmaceutical giant Eli Lilly said on Wednesday the Therapeutic Goods Administration (TGA) had approved the use of its ...
How weight loss demand is draining Europe’s diabetes drug supply, as countries adopt varying speeds of approach to medicinal ...
American teens are increasingly turning to the weight-loss drug Wegovy, as more families and their doctors gain confidence in ...
New prescriptions for Wegovy among teenagers increased by 50% between 2023 and 2024, according to a June 3 report from healthcare data company Truveta. To analyze GLP-1 utilization trends among ...
Rising teen obesity prompts a surge in Novo Nordisk's Wegovy usage among adolescents, with prescriptions climbing 50% in 2024 ...
Regeneron's trevogrumab trial has proved, overall, successful - potentially providing a solution to a reported Wegovy side ...
Wegovy (semaglutide) is approved by the U.S. Food and Drug Administration (FDA) for weight loss and weight management in ...
New data indicates that American teenagers are increasingly using the weight-loss drug Wegovy, as confidence in its use for ...
American teens are increasingly turning to the weight-loss drug Wegovy as more families and their doctors gain confidence in ...
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced on Monday that its experimental drug, when combined with Novo ...
William Tong has taken legal action against two online distributors, Triggered Brand and Made In China, for allegedly selling research-grade GLP-1 weight loss drugs directly to Connecticut consumers ...
Are you weening yourself off a compounded version of the drug? Considering switching insurers in order to keep your ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results